Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1259994
                    [Title] => Oncolytics says Reolysin slowed progression of head and neck cancer in late-stage study
                    [Summary] => 
Oncolytics Biotech said Thursday that its drug Reolysin slowed the progression of head and neck cancers in a late-stage clinical trial.

                    [DatePublished] => 2013-11-23 07:00:06
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img834.imageshack.us/img834/1294/46r7.jpg
                )

        )

)

ONCOLYTICS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1259994
                    [Title] => Oncolytics says Reolysin slowed progression of head and neck cancer in late-stage study
                    [Summary] => 
Oncolytics Biotech said Thursday that its drug Reolysin slowed the progression of head and neck cancers in a late-stage clinical trial.

                    [DatePublished] => 2013-11-23 07:00:06
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img834.imageshack.us/img834/1294/46r7.jpg
                )

        )

)

abtest

Oncolytics says Reolysin slowed progression of head and neck cancer in late-stage study

November 23, 2013 - 7:00am

Oncolytics Biotech said Thursday that its drug Reolysin slowed the progression of head and neck cancers in a late-stage clinical...

Health And Family